Official acquisition announcements and news reports

Rite Aid Wins $200 Million Dispute Over Elixir Sale After Judge's Monday Ruling

Jun 24, 2024, 06:00 PM

Rite Aid has successfully defeated MedImpact Healthcare Systems in a $200 million dispute over the sale of its pharmacy benefit manager, Elixir. A judge ruled on Monday that MedImpact is not entitled to recoup the $200 million in extra costs, as it assumed Elixir's debts when it acquired the company. This ruling absolves Rite Aid of any responsibility for the additional costs tied to the recent acquisition.